This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Prasanna Sreevatsan: Innovator in Cancer Research
Introduction
Prasanna Sreevatsan is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on inhibitors that target specific proteins involved in cancer progression.
Latest Patents
Sreevatsan holds a patent for "Potent and selective azaindole inhibitors of CDK8 and CDK19." This patent includes compounds and pharmaceutical compositions that can be used to treat diseases or disorders associated with CDK8 and/or CDK19. His work in this area is crucial for developing new therapeutic strategies against cancer.
Career Highlights
Prasanna Sreevatsan is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research. His dedication to understanding the molecular mechanisms of cancer has positioned him as a key figure in the scientific community.
Collaborations
Sreevatsan has collaborated with esteemed colleagues such as Nathanael S. Gray and John M. Hatcher. These partnerships enhance the impact of his research and contribute to the collective effort in combating cancer.
Conclusion
Prasanna Sreevatsan's innovative work and patent contributions are vital in the ongoing fight against cancer. His research not only advances scientific knowledge but also holds the potential for developing effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile